86 related articles for article (PubMed ID: 24320143)
21. A knowledge-based weighting approach to ligand-based virtual screening.
Stiefl N; Zaliani A
J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
[TBL] [Abstract][Full Text] [Related]
22. BmStart1, a novel carotenoid-binding protein isoform from Bombyx mori, is orthologous to MLN64, a mammalian cholesterol transporter.
Sakudoh T; Tsuchida K; Kataoka H
Biochem Biophys Res Commun; 2005 Nov; 336(4):1125-35. PubMed ID: 16169523
[TBL] [Abstract][Full Text] [Related]
23. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
24. LigMatch: a multiple structure-based ligand matching method for 3D virtual screening.
Kinnings SL; Jackson RM
J Chem Inf Model; 2009 Sep; 49(9):2056-66. PubMed ID: 19685924
[TBL] [Abstract][Full Text] [Related]
25. How to benchmark methods for structure-based virtual screening of large compound libraries.
Christofferson AJ; Huang N
Methods Mol Biol; 2012; 819():187-95. PubMed ID: 22183538
[TBL] [Abstract][Full Text] [Related]
26. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
Mahasenan KV; Li C
J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
[TBL] [Abstract][Full Text] [Related]
27. High-throughput virtual screening of proteins using GRID molecular interaction fields.
Sciabola S; Stanton RV; Mills JE; Flocco MM; Baroni M; Cruciani G; Perruccio F; Mason JS
J Chem Inf Model; 2010 Jan; 50(1):155-69. PubMed ID: 19919042
[TBL] [Abstract][Full Text] [Related]
28. Providing progesterone for pregnancy: control of cholesterol flux to the side-chain cleavage system.
Strauss JF; Christenson LK; Devoto L; Martinez F
J Reprod Fertil Suppl; 2000; 55():3-12. PubMed ID: 10889829
[TBL] [Abstract][Full Text] [Related]
29. Virtual screening in drug design.
Lill M
Methods Mol Biol; 2013; 993():1-12. PubMed ID: 23568460
[TBL] [Abstract][Full Text] [Related]
30. Structure-based virtual screening protocols.
Good A
Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
[TBL] [Abstract][Full Text] [Related]
31. What we have learned from crystal structures of proteins to receptor function.
Reymond JL; van Deursen R; Bertrand D
Biochem Pharmacol; 2011 Dec; 82(11):1521-7. PubMed ID: 21787757
[TBL] [Abstract][Full Text] [Related]
32. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
Virtanen SI; Pentikäinen OT
J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
[TBL] [Abstract][Full Text] [Related]
33. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
35. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of the MENTAL domain.
Alpy F; Latchumanan VK; Kedinger V; Janoshazi A; Thiele C; Wendling C; Rio MC; Tomasetto C
J Biol Chem; 2005 May; 280(18):17945-52. PubMed ID: 15718238
[TBL] [Abstract][Full Text] [Related]
37. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
38. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
39. What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.
Evans JF; Ferguson AD; Mosley RT; Hutchinson JH
Trends Pharmacol Sci; 2008 Feb; 29(2):72-8. PubMed ID: 18187210
[TBL] [Abstract][Full Text] [Related]
40. StructRank: a new approach for ligand-based virtual screening.
Rathke F; Hansen K; Brefeld U; Müller KR
J Chem Inf Model; 2011 Jan; 51(1):83-92. PubMed ID: 21166393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
